Status:

RECRUITING

Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases

Lead Sponsor:

University Hospital, Rouen

Collaborating Sponsors:

University Hospital, Lille

Groupe Hospitalier Pitie-Salpetriere

Conditions:

Neurogenetic Diseases

Eligibility:

All Genders

Phase:

NA

Brief Summary

Many neurological disorders show a strong genetic basis, from hereditary diseases caused by a single mutation in a given gene, to diseases caused by combinations of strong genetic risk factors. Howeve...

Eligibility Criteria

Inclusion

  • For this project, the inclusion of 3 participant profiles is required:
  • 1a. Patient, major or minor, with a neurological disease affecting the central nervous system, who has already benefited from a genomic analysis (panel, exome or genome sequencing) as part of routine care, with inconclusive analysis because the result was either a variation of uncertain significance or the absence of a variant of interest (patients with inconclusive genomic results).
  • 1b. Patient with neurological disease affecting the central nervous system, of confirmed monogenic or probable oligogenic cause (positive controls).
  • A relative of a type 1a. or 1b. patient with no symptoms of the disease, after the expected age of onset of symptoms in the patient's own family (healthy relatives).
  • For all 3 groups:
  • Affiliation with a social security scheme
  • Agreement to take part in the study with signature of a specific informed consent form for the study.

Exclusion

  • For patients with inconclusive results: Patient with a neurological disease not suspected of a monogenic or oligogenic cause
  • For healthy relatives: existence of a neurological disease (other than uncomplicated migraine) or psychiatric disease (other than simple anxiety stable under treatment).
  • \-

Key Trial Info

Start Date :

January 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 15 2031

Estimated Enrollment :

95 Patients enrolled

Trial Details

Trial ID

NCT06955624

Start Date

January 15 2025

End Date

January 15 2031

Last Update

May 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rouen University Hospital

Rouen, France